Sera Prognostics Stock Price To Earning

SERA Stock  USD 6.38  0.16  2.45%   
Sera Prognostics fundamentals help investors to digest information that contributes to Sera Prognostics' financial success or failures. It also enables traders to predict the movement of Sera Stock. The fundamental analysis module provides a way to measure Sera Prognostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sera Prognostics stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Sera Prognostics Company Price To Earning Analysis

Sera Prognostics' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

P/E

 = 

Market Value Per Share

Earnings Per Share

More About Price To Earning | All Equity Analysis

Sera Price To Earning Driver Correlations

Understanding the fundamental principles of building solid financial models for Sera Prognostics is extremely important. It helps to project a fair market value of Sera Stock properly, considering its historical fundamentals such as Price To Earning. Since Sera Prognostics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sera Prognostics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sera Prognostics' interrelated accounts and indicators.
0.990.970.6-0.63-0.780.89-0.790.71-0.970.990.770.990.97-0.820.49-0.390.47-0.39
0.990.990.7-0.52-0.850.89-0.820.8-1.01.00.780.980.93-0.830.5-0.510.57-0.51
0.970.990.78-0.42-0.910.86-0.830.87-1.00.990.790.940.89-0.830.5-0.610.66-0.61
0.60.70.780.23-0.960.55-0.710.99-0.760.70.660.540.42-0.570.37-0.910.95-0.91
-0.63-0.52-0.420.230.01-0.510.250.090.45-0.53-0.26-0.68-0.780.47-0.24-0.350.34-0.35
-0.78-0.85-0.91-0.960.01-0.720.84-0.990.89-0.85-0.79-0.73-0.620.65-0.370.81-0.850.81
0.890.890.860.55-0.51-0.72-0.590.66-0.890.890.560.90.88-0.870.61-0.330.38-0.33
-0.79-0.82-0.83-0.710.250.84-0.59-0.760.82-0.81-0.97-0.76-0.670.380.010.53-0.580.53
0.710.80.870.990.09-0.990.66-0.76-0.850.80.710.660.55-0.670.44-0.870.91-0.87
-0.97-1.0-1.0-0.760.450.89-0.890.82-0.85-1.0-0.79-0.96-0.90.83-0.510.57-0.630.57
0.991.00.990.7-0.53-0.850.89-0.810.8-1.00.780.980.94-0.840.5-0.510.56-0.51
0.770.780.790.66-0.26-0.790.56-0.970.71-0.790.780.730.63-0.350.07-0.40.59-0.4
0.990.980.940.54-0.68-0.730.9-0.760.66-0.960.980.730.99-0.820.46-0.340.39-0.34
0.970.930.890.42-0.78-0.620.88-0.670.55-0.90.940.630.99-0.810.44-0.250.25-0.25
-0.82-0.83-0.83-0.570.470.65-0.870.38-0.670.83-0.84-0.35-0.82-0.81-0.840.45-0.490.45
0.490.50.50.37-0.24-0.370.610.010.44-0.510.50.070.460.44-0.84-0.20.45-0.2
-0.39-0.51-0.61-0.91-0.350.81-0.330.53-0.870.57-0.51-0.4-0.34-0.250.45-0.2-0.841.0
0.470.570.660.950.34-0.850.38-0.580.91-0.630.560.590.390.25-0.490.45-0.84-0.84
-0.39-0.51-0.61-0.91-0.350.81-0.330.53-0.870.57-0.51-0.4-0.34-0.250.45-0.21.0-0.84
Click cells to compare fundamentals
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition

Sera Retained Earnings

Retained Earnings

(259.24 Million)

At present, Sera Prognostics' Retained Earnings are projected to decrease significantly based on the last few years of reporting.
Based on the latest financial disclosure, Sera Prognostics has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earning for all United States stocks is 100.0% higher than that of the company.

Sera Price To Earning Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sera Prognostics' direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sera Prognostics could also be used in its relative valuation, which is a method of valuing Sera Prognostics by comparing valuation metrics of similar companies.
Sera Prognostics is currently under evaluation in price to earning category among its peers.

Sera Prognostics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Sera Prognostics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Sera Prognostics' managers, analysts, and investors.
Environmental
Governance
Social

Sera Fundamentals

About Sera Prognostics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Sera Prognostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sera Prognostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sera Prognostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Sera Prognostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sera Prognostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sera Prognostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sera Prognostics Stock:
Check out Sera Prognostics Piotroski F Score and Sera Prognostics Altman Z Score analysis.
For information on how to trade Sera Stock refer to our How to Trade Sera Stock guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sera Prognostics. If investors know Sera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sera Prognostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.99)
Revenue Per Share
0.003
Quarterly Revenue Growth
(0.31)
Return On Assets
(0.27)
Return On Equity
(0.50)
The market value of Sera Prognostics is measured differently than its book value, which is the value of Sera that is recorded on the company's balance sheet. Investors also form their own opinion of Sera Prognostics' value that differs from its market value or its book value, called intrinsic value, which is Sera Prognostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sera Prognostics' market value can be influenced by many factors that don't directly affect Sera Prognostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sera Prognostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sera Prognostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sera Prognostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.